[IRMA press release]   Trial Design Significantly Enhanced By Strong Community Input October 2, 2013 – IRMA applauds the launch of the world’s first-ever Phase II rectal microbicide trial. The Microbicide Trial Network’s study, called MTN-017, will test a reduced glycerin formulation of tenofovir gel applied rectally. Volunteers consisting of gay men, other men who have sex Read More >>

Find out a little about Hailey Gilmore in her interesting mini-bio, the latest in IRMA’s “Meet a Friendly Rectal Microbicide Advocate” series on the IRMA website here.  Hailey is one of five new bios we are featuring.  Hailey GilmoreSan Francisco, California, USA Hailey Gilmore studied international development in college and was always interested in sexual health promotion Read More >>

As many of our readers  know – in December IRMA, the Microbicide Trials Network, and Population Council launched the video “The Rectal Revolution is Here: An introduction to rectal microbicide clinical trials.” The 14-minute video includes researchers, advocates, and trial participants and discusses the need for rectal microbicides and the role of clinical trials in developing products Read More >>

— Now Playing —   “The Rectal Revolution is Here: An introduction to rectal microbicide clinical trials” on YouTube. The vid, developed by IRMA, Microbicide Trials Network, and Population Council, is available in English,  Spanish and Thai languages. Watch to learn about the need for rectal microbicides, how clinical trials work, and the importance of volunteers in the Read More >>

[Click here for the VOICE press release – “Daily HIV Prevention Approaches Didn’t Work for African Women in the VOICE Study” – from the Microbcide Trials Network] IRMA, like the rest of new prevention technology researchers and advocates, is disappointed to learn that daily oral Truvada was not found to be an effective HIV intervention among the African women at Read More >>

HIV prevention organizations debut The Rectal Revolution Is Here: An Introduction to Rectal Microbicide Clinical Trials in advance of first-ever Phase II rectal microbicide trial   [Press Release] International Rectal Microbicide Advocates (IRMA), the Population Council, and the Microbicide Trials Network (MTN) today released a collaborative video project called The Rectal Revolution Is Here: An Introduction to Read More >>

Below is an adapted version of the official MTN press release that went out moments ago on this study and associated PLoS One paper (“Is Wetter Better? An Evaluation of Over-the-Counter Personal Lubricants for Safety and Anti-HIV-1 Activity”). The IRMA modifications to the release – which do not alter any facts – underscore and emphasize that the study involved exposing human tissues to HIV in Read More >>

Check out this interesting mini-bio of  Clare Collins, the latest in IRMA’s “Meet a Friendly Rectal Microbicide Advocate” series on the IRMA website here.  Clare  is one of five new bios posted October 30, 2012. Clare CollinsPittsburgh, Pennsylvania, USA “I think rectal microbicides just make sense. The idea of a product that people might actually WANT to use Read More >>

via Citizens News Service, by Somya Arora According to the Microbicides Trials Network (MTN), HIV continues to disproportionately affect racial minorities and men who have sex with men (MSM). MTN estimates that 5 to 10 percent of the world’s population engages in anal sex and globally, MSM are 19 times more likely to be infected with HIV Read More >>

Please Register for this Teleconference!  Please join IRMA, AVAC and Ian McGowan, co-principal investigator of the Microbicide Trials Network and Principal Investigator of CHARM (the Combination HIV Antiretroviral Rectal Microbicide Program) for a thoroughly CHARMing teleconference update on what is happening with this innovative program. Funded by the U.S. National Institutes of Health in 2009, CHARM is Read More >>